EMD-1214063 is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. It binds to MET tyrosine kinase and disrupts MET signal transduction pathways, which may induce apoptosis in tumor cells overexpressing this kinase.
More Information Supplier PageEMD-1214063 is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. It binds to MET tyrosine kinase and disrupts MET signal transduction pathways, which may induce apoptosis in tumor cells overexpressing this kinase.
More Information Supplier PageMK-0974 (Telcagepant) is a potent and selective antagonist of the human and rhesus CGRP receptors.
More Information Supplier PageMK-0974 (Telcagepant) is a potent and selective antagonist of the human and rhesus CGRP receptors.
More Information Supplier PageMK-0974 (Telcagepant) is a potent and selective antagonist of the human and rhesus CGRP receptors.
More Information Supplier PageMK-0974 (Telcagepant) is a potent and selective antagonist of the human and rhesus CGRP receptors.
More Information Supplier PageGW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain
More Information Supplier PageBMN-673 is an orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity.
More Information Supplier PageBMN-673 is an orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity.
More Information Supplier PageBMN-673 is an orally bioavailable inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential antineoplastic activity.
More Information Supplier Page
